relapsed/refractory | International Myeloma Foundation

African-American female researcher in laboratory

Week in Review

March 26

February and March 2026: What's New in Myeloma? 

attendees of an ASH 2025 presentation

Week in Review

February 12

Dr. Joseph Mikhael's Top 10 Myeloma Abstracts from ASH 2025

Patient being assured by doctor

Week in Review

February 5

Frequently Asked Questions (FAQ): The Updated ASCO Living Guideline for Multiple Myeloma

researcher doing lab work blood samples

Week in Review

January 29

December 2025 and January 2026: What's New in Myeloma?

team of healthcare professionals

Week in Review

December 18

November and December 2025: What's New in Myeloma?

scientist in lab with pipette

Week in Review

September 25

August and September 2025: What's New in Myeloma?

female scientist doing lab work

Week in Review

August 28

July and August 2025: What's New in Myeloma?  

Top Myeloma Research Patient Perspective

Week in Review

August 14

Key Takeaways from the Top Myeloma Research Presented at ASCO, EHA, & IMWG 2025 Webinar: The Patient Perspective (Part 2 of 2)

doctor prescribing medicine

Week in Review

July 31

June and July 2025: What's New in Myeloma?

Neils Van De Donk ASCO 2025

June 19

First-in-human JNJ-79635322 trispecific antibody study in RRMM patients: Initial phase 1 results

telehealth communication

Week in Review

May 29

April and May 2025: What's New in Myeloma? 

MagnetisMM3

February 25

MagnetisMM-3: Long-Term Efficacy & Safety of Less Frequent Elranatamab Dosing in Relapsed Refractory Multiple Myeloma

Subscribe to relapsed/refractory

Give Where Most Needed